Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 536,896 | 528,593 | 535,075 | 493,105 | 510,034 |
| Cost of Goods | 370,494 | 330,082 | 322,577 | 301,543 | 342,962 |
| Gross Profit | 166,402 | 198,511 | 212,498 | 191,562 | 167,072 |
| Operating Expenses | 155,721 | 170,078 | 145,956 | 146,198 | 147,856 |
| Operating Income | 11,175 | 28,515 | 67,119 | 45,907 | 20,178 |
| Interest Expense | 33,957 | 34,400 | 34,083 | 33,885 | 34,535 |
| Other Income | 6,463 | 3,842 | 1,788 | 2,882 | 8,880 |
| Pre-tax Income | -16,319 | -2,043 | 34,824 | 14,904 | -5,477 |
| Income Tax | 4,140 | 4,049 | 2,648 | 359 | 1,485 |
| Net Income Continuous | -20,459 | -6,092 | 32,176 | 14,545 | -6,962 |
| Minority Interests | -15,937 | N/A | 17,644 | 7,839 | -16,983 |
| Net Income | $-4,522 | $-6,092 | $14,532 | $6,706 | $10,021 |
| EPS Basic Total Ops | -0.05 | -0.03 | 0.10 | 0.05 | -0.02 |
| EPS Basic Continuous Ops | -0.14 | -0.04 | 0.22 | 0.10 | -0.05 |
| EPS Diluted Total Ops | -0.04 | -0.03 | 0.10 | 0.04 | -0.03 |
| EPS Diluted Continuous Ops | -0.13 | -0.04 | 0.21 | 0.10 | -0.05 |
| EBITDA(a) | $74,688 | $91,101 | $125,897 | $103,639 | $82,280 |